search button
Open Access

Relief of diabetes by duodenal‑jejunal bypass sleeve implantation in the high‑fat diet and streptozotocin‑induced diabetic rat model is associated with an increase in GLP‑1 levels and the number of GLP‑1‑positive cells

  • Authors:
    • Jinquan Shuang
    • Ying Zhang
    • Limei Ma
    • Xueming Tan
    • Jing Huang
    • Xiang Wang
    • Guanyin Xiong
    • Zhonghua Jiang
    • Xiuhua Zhang
    • Shiqing Du
    • Yongsong Gu
    • Xiangyang Shi
    • Zhining Fan

  • View Affiliations

  • Published online on: August 4, 2015     https://doi.org/10.3892/etm.2015.2669
  • Pages: 1355-1363

  • Copyright: © Shuang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

A recently invented duodenal‑jejunal bypass sleeve (DJBS) implanted in the duodenum and proximal jejunum has exhibited good glycemic control in diabetes mellitus. However, the specific mechanism by which DJBS placement induces the remission of diabetes is not well known. Previous studies have indicated that changes in the pattern of gut hormone secretion may play a role. The aim of the present study was to explore the role of intestinal L cells and the production of glucagon‑like peptide‑1 (GLP‑1) by these cells in DJBS implantation‑induced glycemic control in diabetic rats. A DJBS was placed in the proximal small intestine of rats with diabetes induced by a high‑fat diet and low‑dose streptozotocin (STZ), and the effects of the DJBS on the remission of diabetes and the GLP‑1 levels of plasma and intestinal tissues were investigated 12 weeks after DJBS placement. The number of intestinal GLP‑1 positive cells was also counted. When the DJBS had been in place for 12 weeks, the plasma glucose level of the DJBS‑implanted rats decreased significantly from 23.33±1.56 mmol/l prior to surgery to 7.70±0.84 mmol/l and the diabetes mellitus was relieved completely; however, diabetic control rats and diabetic rats subjected to sham surgery did not show any improvement. Parallel with the remission of diabetes, the plasma and distal ileum GLP‑1 levels of rats in the DJBS implantation group were also higher than those of rats in the diabetic control and sham surgery groups. The number of GLP‑1‑positive cells in the distal ileum was also higher in the DJBS implantation group than in the diabetic control and sham surgery groups (31.0±2.6 vs. 23.5±4.4 vs. 23.0±3.2 respectively; P<0.01). DJBS implantation effectively led to the remission of diabetes in rats with diabetes induced by a high‑fat diet and low‑dose STZ when implanted for 12 weeks. The remission of diabetes may be associated with the increase in the number of L cells and elevation of GLP‑1 levels induced by DJBS implantation.
View Figures
View References

Related Articles

Journal Cover

October-2015
Volume 10 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.4
  • Ranked Medicine Research and Experimental
    (total number of cites)
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Shuang J, Zhang Y, Ma L, Tan X, Huang J, Wang X, Xiong G, Jiang Z, Zhang X, Du S, Du S, et al: Relief of diabetes by duodenal‑jejunal bypass sleeve implantation in the high‑fat diet and streptozotocin‑induced diabetic rat model is associated with an increase in GLP‑1 levels and the number of GLP‑1‑positive cells. Exp Ther Med 10: 1355-1363, 2015.
APA
Shuang, J., Zhang, Y., Ma, L., Tan, X., Huang, J., Wang, X. ... Fan, Z. (2015). Relief of diabetes by duodenal‑jejunal bypass sleeve implantation in the high‑fat diet and streptozotocin‑induced diabetic rat model is associated with an increase in GLP‑1 levels and the number of GLP‑1‑positive cells. Experimental and Therapeutic Medicine, 10, 1355-1363. https://doi.org/10.3892/etm.2015.2669
MLA
Shuang, J., Zhang, Y., Ma, L., Tan, X., Huang, J., Wang, X., Xiong, G., Jiang, Z., Zhang, X., Du, S., Gu, Y., Shi, X., Fan, Z."Relief of diabetes by duodenal‑jejunal bypass sleeve implantation in the high‑fat diet and streptozotocin‑induced diabetic rat model is associated with an increase in GLP‑1 levels and the number of GLP‑1‑positive cells". Experimental and Therapeutic Medicine 10.4 (2015): 1355-1363.
Chicago
Shuang, J., Zhang, Y., Ma, L., Tan, X., Huang, J., Wang, X., Xiong, G., Jiang, Z., Zhang, X., Du, S., Gu, Y., Shi, X., Fan, Z."Relief of diabetes by duodenal‑jejunal bypass sleeve implantation in the high‑fat diet and streptozotocin‑induced diabetic rat model is associated with an increase in GLP‑1 levels and the number of GLP‑1‑positive cells". Experimental and Therapeutic Medicine 10, no. 4 (2015): 1355-1363. https://doi.org/10.3892/etm.2015.2669